169 related articles for article (PubMed ID: 3410601)
1. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
Raz I; Hussein Z; Samara E; Ben-David J
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
Raz I; Ben-David J; Hussein Z; Samara E
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
[TBL] [Abstract][Full Text] [Related]
6. A comparative bioavailability study on two sustained-release formulations of diclofenac sodium following a single dose administration.
Hasan MM; Najib NM; Muti H
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):387-91. PubMed ID: 8225684
[TBL] [Abstract][Full Text] [Related]
7. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
[TBL] [Abstract][Full Text] [Related]
8. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
[TBL] [Abstract][Full Text] [Related]
9. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.
Mascher H
Drug Des Deliv; 1989 Jun; 4(4):303-11. PubMed ID: 2775450
[TBL] [Abstract][Full Text] [Related]
12. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
Walter K; von Nieciecki A
Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
[TBL] [Abstract][Full Text] [Related]
13. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers.
Mendes GB; Franco LM; Moreno RA; Fernandes AG; Muscara MN; de Nucci G
Int J Clin Pharmacol Ther; 1994 Mar; 32(3):131-5. PubMed ID: 8205374
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of two different diclofenac formulations in healthy volunteers.
Silva LC; Simões IG; Lerner FE; Belém GR; de Moraes ME; De Nucci G
Arzneimittelforschung; 1999 Nov; 49(11):920-4. PubMed ID: 10604045
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.
De Bernardi di Valserra M; Feletti F; Tripodi AS; Contos S; Carabelli A; Maggi L; Germogli R
Arzneimittelforschung; 1993 Mar; 43(3):373-7. PubMed ID: 8489569
[TBL] [Abstract][Full Text] [Related]
17. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.
Macía MA; Frias J; Carcas AJ; Guerra P; Valiente R; Lucero ML
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):333-9. PubMed ID: 7582384
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose].
Kurapov AP; Starodubtsev AK; Rubtsova TM; Ignat'ev VG; Kemenova VA
Eksp Klin Farmakol; 1995; 58(1):53-4. PubMed ID: 7787700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
